Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Natural molecule may be key to reversing and halting heart disease in diabetes

Natural molecule may be key to reversing and halting heart disease in diabetes

Credit: CC0 Public Domain

An international collaboration jointly led by University College Dublin (UCD) and Monash University in Melbourne has found that mimicking the activity of molecules found naturally in the body may provide a new approach to treating vascular disease in diabetes.

Diabetes presents an enormous global health challenge. Currently 425 million people have diabetes and this is expected to rise to 750 million by 2025. It is estimated that 10% of our national healthcare budget relates to the management of diabetes and related complications.

People with diabetes have a high incidence of cardiovascular disease. A build-up of fat and immune cells [plaque] on blood vessels causes inflammation and plaque development. If a plaque ruptures, it can clog up a blood vessel and starve the brain of oxygen, resulting in stroke.

In healthy conditions, the body produces special messenger molecules that tightly control inflammation. In diseases such as diabetes, inflammation can become so vigorous that it overwhelms the activity of these messengers and rages out of control.

This research study carried out by Dr. Eoin Brennan in UCD and investigators in Melbourne as part of an EU funded project took a radical approach of mimicking the activity of these messengers using a synthetic version of a molecule called lipoxin.

“I first worked with colleagues in the UCD School of Chemistry led by Professor Patrick Guiry to design a synthetic version of lipoxin called Benzo-LXA4. Then, I went to the laboratory of Professor Mark Cooper and Dr. Phillip Kantharidis in Melbourne to look at the potential of using natural lipoxin and this synthetic mimic to treat vascular complications in diabetic animals. We were excited to find that not only did this decrease the amount of plaque in the blood vessels, it reversed established heart disease”, explained Dr. Brennan.

Dr. Brennan returned to UCD for the next stage of the project, which involved treating human carotid plaque tissue with these protective molecules to see if the findings in the laboratory were also relevant in the clinic. To do this, Ms Mary Barry and a team of vascular surgeons at St Vincent’s University Hospital, Dublin provided carotid plaque biopsy tissue after surgery to enable the UCD researchers to test the effects of the lipoxin drugs on patient tissue.

By taking the plaque tissue from human blood vessels and exposing it to lipoxin molecules in the laboratory, the research team found that inflammation was reduced. These results provide insights into the process of vascular damage seen in atherosclerosis, particularly in the diabetes setting, and identify lipoxins as a novel therapeutic for diabetic complications.

Importantly, the team showed that lipoxins could prevent the progression of atherosclerosis in animals with established atherosclerotic lesions. The study builds on earlier work by these scientists that showed these compounds reversed established diabetic kidney disease.

Co-senior author, Professor Catherine Godson, Director of the UCD Diabetes Complications Research Centre and Fellow of UCD Conway Institute said, “This study highlights lipoxins as protective against diabetes-associated complications, such as accelerated atherosclerosis. It is important to recognise the novelty of this approach. The problems with anti-inflammatory drugs are well documented.

Here, we used an alternative, kinder and gentler approach than merely blocking inflammation. Instead, we have promoted its resolution by mimicking processes that keep us healthy. Based on these findings, we recently secured international support from the Juvenile Diabetes Research Foundation to look at how these lipoxin molecules interact with existing anti-diabetic therapies.”

Professor Mark Cooper, Head of the Diabetes Department in Monash University Central Clinical School and a world leading researcher in the field of diabetes and its complications said, “In itself, this international collaboration has proved to be a truly fantastic example of translational medicine research; bringing together synthetic chemists with biomedical researchers and clinicians to move findings from laboratory models to ex-vivo tissue samples from patients.”

The research is published in the current issue of the journal Diabetes.


Explore further:
Aortic atherosclerotic plaque inflammation may contribute to the progression of fatty liver disease to liver fibrosis

More information:
E. P. Brennan et al. Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis, Diabetes (2018). DOI: 10.2337/db17-1317

Journal reference:
Diabetes

Provided by:
University College Dublin

Tagged with:

About author

Related Articles